Digital Revolution Will Not Be Free: Facilitating OTC Switches, Engaging Consumers
This article was originally published in The Tan Sheet
Executive Summary
Digital technologies could transform how consumers shop for OTC drugs in stores, but costs could be significant, say industry consultants. Marketers are looking to create digital “touch points” such as interactive kiosks to create two-way communication between brands and customers.
You may also be interested in...
FDA Aims To “NSURE” Clarity About New Paradigm For OTC Switches
FDA official Rikin Mehta assures stakeholders that the proposed new paradigm for Rx-to-OTC switches would not create a third class of drugs, give pharmacists prescribing power or eliminate the need for consumers to visit doctors.
Sanofi Allegra Switch Approval Triggers Race To Market For Perrigo
Sanofi-Aventis will launch nonprescription Allegra allergy relief products March 4, but the line might not beat private-label fexofenadine products to store shelves.
Target Corp.'s ‘Clean’ Marketing Challenged In Consumer Class Action
The mega-retailer is defending a proposed class action in Minnesota federal court over its ‘Target Clean’ marketing and label, which it has awarded "independently" to around 4,000 products in its stores. Consumer plaintiffs allege some offerings contain ingredients on the program's “formulated without” list, as well as other hazardous substances that ought not be in clean products. Pending litigation against Sephora stands to be influential.